Mr. Clint Sharples reports

HERITAGE CANNABIS HOLDINGS CORP. COMMENDS CONSTELLATION BRANDS STRATEGIC INVESTMENT IN CANOPY GROWTH

Heritage Cannabis Holdings Corp. and its subsidiary, PhyeinMed Inc., a licensed producer by Health Canada, commends Constellation Brands for supporting Canopy Growth Corp. with their recent investment of potentially $5-billion to address the recreational and medical markets.

In March of this year, PhyeinMed signed an updated wholesale agreement with Canopy Growth to supply cannabis and cannabis products to the marketplace via Tweed Main Street website. This amended three-year agreement addresses the supply of both recreational and medicinal cannabis.

"Constellation's expanded investment with Canopy Growth, substantiates our belief that both the Canadian and global cannabis market will continue to see significant growth," states Clint Sharples, chairman of Heritage Cannabis Holdings. "We agree with this vision, and we want to make sure Heritage is properly positioned to take advantage of this progression."

About Heritage Cannabis Holdings Corp.

The company is currently listed as a marijuana issue having a 75-per-cent interest in PhyeinMed Inc., a Health Canada late-stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a parent and development company with strategic plans to continue to acquire cannabis-related companies.

We seek Safe Harbor.